301 related articles for article (PubMed ID: 28787269)
21. Strategy to diagnose monoclonal gammopathies in serum: high-resolution electrophoresis, immunofixation, and kappa/lambda quantification.
Keren DF; Warren JS; Lowe JB
Clin Chem; 1988 Nov; 34(11):2196-201. PubMed ID: 3141081
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
[TBL] [Abstract][Full Text] [Related]
23. Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies.
Katzmann JA; Snyder MR; Rajkumar SV; Kyle RA; Therneau TM; Benson JT; Dispenzieri A
Clin Chem; 2011 Dec; 57(12):1687-92. PubMed ID: 21980167
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
Wolff F; Thiry C; Willems D
Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
[TBL] [Abstract][Full Text] [Related]
26. Performance evaluation of the Helena V8 capillary electrophoresis system.
Poisson J; Fedoriw Y; Henderson MP; Hainsworth S; Tucker K; Uddin Z; McCudden CR
Clin Biochem; 2012 Jun; 45(9):697-9. PubMed ID: 22465274
[TBL] [Abstract][Full Text] [Related]
27. [Diagnostic accuracy of serum protein electrophoresis and free light chain measurements for monoclonal gammopathies].
Peña C; Ortiz M; Voisin J; Peralta A; Balboa V; Delgado F
Rev Med Chil; 2018 Jan; 146(1):64-67. PubMed ID: 29806679
[TBL] [Abstract][Full Text] [Related]
28. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
29. Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies.
Lee WS; Singh G
J Clin Med Res; 2018 Jul; 10(7):562-569. PubMed ID: 29904440
[TBL] [Abstract][Full Text] [Related]
30. [Monoclonal gammopathies in a series of 1683 plasma donors].
Tichý M; Rehácek V; Maisnar V; Dominiková K; Palicka V
Cas Lek Cesk; 2004; 143(6):401-4; discussion 404. PubMed ID: 15309868
[TBL] [Abstract][Full Text] [Related]
31. Urine immunofixation electrophoresis remains important and is complementary to serum free light chain.
Levinson SS
Clin Chem Lab Med; 2011 Nov; 49(11):1801-4. PubMed ID: 21663562
[TBL] [Abstract][Full Text] [Related]
32. High false-positive rate for monoclonal gammopathy using capillary electrophoresis (CAPILLARYS 2) alone.
Huang RS; Oleske DA; Tholpady A; Chang BN; Dasgupta A; Nguyen A; Wahed A
J Clin Lab Anal; 2014 Jan; 28(1):42-6. PubMed ID: 24375896
[TBL] [Abstract][Full Text] [Related]
33. Immunofixation compared with immunoelectrophoresis for the routine characterization of paraprotein disorders.
Gerard SK; Chen KH; Khayam-Bashi H
Am J Clin Pathol; 1987 Aug; 88(2):198-203. PubMed ID: 3618552
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal gammopathy in a tertiary referral hospital.
Tamimi W; Alaskar A; Alassiri M; Alsaeed W; Alarifi SA; Alenzi FQ; Jawdat D
Clin Biochem; 2010 Jun; 43(9):709-13. PubMed ID: 20206156
[TBL] [Abstract][Full Text] [Related]
35. Screening and Diagnosis of Monoclonal Gammopathies: An International Survey of Laboratory Practice.
Genzen JR; Murray DL; Abel G; Meng QH; Baltaro RJ; Rhoads DD; Delgado JC; Souers RJ; Bashleben C; Keren DF; Ansari MQ
Arch Pathol Lab Med; 2018 Apr; 142(4):507-515. PubMed ID: 29266967
[TBL] [Abstract][Full Text] [Related]
36. Serum protein electrophoresis and immunofixation by a semiautomated electrophoresis system.
Bossuyt X; Bogaerts A; Schiettekatte G; Blanckaert N
Clin Chem; 1998 May; 44(5):944-9. PubMed ID: 9590366
[TBL] [Abstract][Full Text] [Related]
37. Serum and Urine Protein Electrophoresis and Serum-Free Light Chain Assays in the Diagnosis and Monitoring of Monoclonal Gammopathies.
Singh G
J Appl Lab Med; 2020 Nov; 5(6):1358-1371. PubMed ID: 33150391
[TBL] [Abstract][Full Text] [Related]
38. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease.
Levinson SS
Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046
[TBL] [Abstract][Full Text] [Related]
39. Identification of Paraproteins via Serum Immunofixation or Serum Immunosubtraction and Immunoturbidimetric Quantitation of Serum Immunoglobulins in the Laboratory Testing for Monoclonal Gammopathies.
Mrosewski I; Urbank M
Arch Pathol Lab Med; 2021 Dec; 145(12):1552-1557. PubMed ID: 33635966
[TBL] [Abstract][Full Text] [Related]
40. Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios.
Bradwell AR; Harding SJ; Fourrier NJ; Wallis GL; Drayson MT; Carr-Smith HD; Mead GP
Clin Chem; 2009 Sep; 55(9):1646-55. PubMed ID: 19617289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
